Organ preservation for transplantation involves the process of maintaining organs outside of the body in a viable state before they are transplanted into a recipient. This is crucial to ensure the organs remain functional and viable during the period between removal from the donor and transplantation into the recipient. Various methods of organ preservation are used, including cold storage and machine perfusion.

Cold storage involves placing the organ in a cold solution to slow down metabolism and reduce cellular damage, while machine perfusion involves pumping a preservation solution through the organ to maintain its function and viability. Organ preservation techniques aim to minimize ischemic injury, preserve organ function, and extend the time window for transplantation, ultimately improving the success rates of organ transplantation and increasing the availability of organs for patients in need.

The global Organ Preservation for Transplantation market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Organ Preservation for Transplantation Industry Forecast” looks at past sales and reviews total world Organ Preservation for Transplantation sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ Preservation for Transplantation sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Organ Preservation for Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest developments, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Organ Preservation for Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ Preservation for Transplantation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Preservation for Transplantation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Preservation for Transplantation.

United States market for Organ Preservation for Transplantation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Organ Preservation for Transplantation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Organ Preservation for Transplantation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Organ Preservation for Transplantation players cover:

• TransMedics
• Lung Bioengineering
• OrganOx
• XVIVO
• TNO

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of the Organ Preservation for Transplantation market by product type, application, key players, and key regions and countries.

Segmentation by Type:

• Heart Preservation
• Liver Preservation
• Kidney Preservation
• Lung Preservation

Segmentation by Application:

• Organ Transplant Specialist Hospitals
• Organ Banks
• Pharmaceutical Research Organizations

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• TransMedics
• Lung Bioengineering
• OrganOx
• XVIVO
• TNO
• UHN
• SCREEN
• Bridge to Life
• Organ Recovery Systems
• Institut Georges Lopez
• Ebers
• Paragonix Technologies